跳至主要内容
临床试验/JPRN-jRCT1080222828
JPRN-jRCT1080222828未知Unknown

A multicenter, longitudinal, non-drug study to assess the suitability of neurocognitive tests and functioning scales for the measurement of cognitive and functioning changes in Japanese individuals with Down syndrome aged 6-30.

Chugai Pharmaceutical Co., Ltd.0 个研究点目标入组 40 人开始时间: 2015年4月15日最近更新:
适应症

试验速览

阶段
Unknown
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 6age old 至 <= 30age old(—)
性别
All

入选标准

  • *Subjects with diagnosis of Down Syndrome.Subjects may have standard trisomy 21, Robertsonian translocation, isochromosome21,Down syndrome with reciprocal translocation or mosaicism.
  • *Availability of parent or other reliable caregiver who agrees to accompany the subject to clinic visits, provide information about the subject's behavior and symptoms.
  • *Down Syndrome subjects meeting clinical diagnostic criteria for generalized anxiety disorders, major depressive disorders, autism spectrum disorder, attention deficit and hyperactivity disorder, can participate to the study provided they are on stable medication for at least 8 weeks prior to screening.

排除标准

  • Individuals who may not be able to comply with the protocol or perform the outcome measures due to significant hearing or visual impairment or other issues judged relevant by the investigators.

研究者

相似试验